[Steps in the treatment of ovarian cancer].
The paclitaxel/cisplatin regimen is superior to standard therapy PC based on higher overall response rates, higher negative second-look laparotomy rate and overall survival. The regimen paclitaxel/cisplatin/cyclophosphamide seem to give the best treatment results. Interval debulking surgery after initial laparotomy and intraperitoneal therapy with cisplatin and i.v. cyclophosphamide in patients with residual disease improve overall survival rate.
Kliniki Onkologii Akademii Medycznej w Poznaniu.
J
J
Markowska
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007813:Laparotomy; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000601:surgery
D000970:Antineoplastic Agents
Postepy w leczeniu raka jajnika.